我院药物临床试验中严重不良事件报告233例分析  

Analysis of 233 Cases of Severe Adverse Events in Drug Clinical Trials of Our Hospital

作　　者：张田香[1] 陆明莹[1] 张彩霞[1] 袁祖贻[1] 

机构地区：[1]西安交通大学第一附属医院临床药理机构办公室,西安710061

出　　处：《中国药房》2016年第23期3210-3212,共3页China Pharmacy

基　　金：西安交通大学第一附属医院科研发展基金项目(No.2014YK38)

摘　　要：目的:为药物临床试验中进行质控和保护受试者权益提供参考。方法:收集我院2012年1月-2015年6月上报的药物临床试验中的233例严重不良事件(SAE)报告,按照受试者性别、年龄、上报科室、药物/器械种类、药物/器械名称、SAE的类型、SAE与药物/器械的相关性、受试者合并疾病情况等进行统计分析。结果:男性SAE发生率高于女性(71.2%vs.28.8%);SAE主要发生在50岁以上的人群中(189例,81.1%);心内科SAE发生率最高(137例,58.8%);主要的SAE类型是导致住院(183例,78.5%);大部分SAE与研究药物肯定无关(164例,70.4%);发生SAE的受试者中一半以上自身合并有其他疾病(128例,54.9%)。结论:为确保药物临床试验数据的质量和受试者的安全,临床试验过程中研究者应重点加强对老年和自身合并疾病受试者的管理,确保每例SAE得到及时处理,并如实记录和报告。OBJECTIVE：To provide reference for performing quality control and protecting the subjects＇ rights and interests.METHODS：233 severe adverse events（SAE）cases reported by our hospital during Jan. 2012-Jun. 2015 were collected and analyzed statistically in respects of subjects＇ gender and age,department,drug/equipment types,SAE types,relationship of SAE with drug/equipment,comorbidities,etc. RESULTS：The incidence of SAE in male was higher than female（71.2% vs. 28.8%）;SAE mainly occurred in people over the age of 50（189 cases,81.1%）;the incidence of SAE in cardiology department was the highest（137 cases,58.8%）;main SAE type was hospitalization（183 cases,78.5%）;most of SAE had nothing to do with studied drugs（164 cases,70.4%）;more than half of the subjects suffered from other comorbidities（128 cases,54.9%）. CONCLUSIONS：In order to ensure the quality of drug clinical trial data and safety of subjects,the investigator should strengthen the management of the elderly subjects and those suffering from comorbidities,to ensure that each SAE case is timely processed and accurately recorded and reported.

关 键 词：严重不良事件 药物临床试验 受试者 分析 

分 类 号：R969.3[医药卫生—药理学]